AIDTES
Software Diagnostic Solutions for PCR Tests
Company Overview
Snapshot
Founded in April 2020 by Rian Twizer, AIDTES operated with 1–10 employees, developing software solutions for PCR test analysis and interpretation. The company ceased operations in February 2023.
Business overview
AIDTES specialized in developing and implementing novel software solutions for the analysis, interpretation, and connectivity of clinical molecular diagnostics. Their core product automated high-throughput PCR tests, focusing on data security, cost reduction, efficiency, and accuracy. The solution was designed for on-premises or cloud-based deployment and could be customized for various qPCR tests, serving markets including laboratories, healthcare providers, airports, and enterprises within the digital healthcare and medical devices sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is AIDTES's primary business?
- AIDTES develops and implements software solutions for the analysis, interpretation, and connectivity of clinical molecular diagnostics, specifically automating high-throughput PCR tests.
- When was AIDTES founded and by whom?
- AIDTES was founded in April 2020 by Rian Twizer.
- What is the status of AIDTES?
- AIDTES ceased to operate in February 2023.
- What technology does AIDTES utilize in its solutions?
- AIDTES leverages artificial intelligence, machine learning, and cloud-based software platforms to provide its diagnostic solutions.
- Which markets did AIDTES target with its software?
- AIDTES targeted healthcare providers, laboratories, airports, and enterprises across Europe, Africa, Asia, Americas, and Australia with its software solutions.